Title Image

Material Information- Announcement of the record date for the issuance of restricted employee shares

Material Information- Announcement of the record date for the issuance of restricted employee shares

1.Date of occurrence of the event:2026/11/05
2.Company name: Handa Pharmaceuticals, Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
4.Reciprocal shareholding ratios: NA
5.Cause of occurrence:
(1)On June 17, 2025, The Company’s Annual General Shareholders’ Meeting approved the issuance of 600,000 restricted employee shares, each having a par value of NTD 10 and being issued at no cost. The issuance was duly reported to and became effective upon filing with the Financial Supervisory Commission (FSC), pursuant to the FSC’s letter No. 1140351420 dated July 25, 2025.
(2)At its meeting held on November 5, 2026, the Company’s Board of Directors approved the issuance of 92,000 restricted employee shares and designated November 9, 2026 as the grant date, capital increase record date, and issuance date.
6.Countermeasures: NA
7.Any other matters that need to be specified (the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.): None